SecBot SecBot
144 ·Filed Nov 3, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed13d 13h ago SEC0001959173-26-007669
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small and routine, likely for tax purposes. Monitor for any larger insider sales or changes in officer shareholding patterns in upcoming Form 4 filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$11.22
T+0 close · Nov 3, 2026 · via day close
Latest settled
+17.20%
T+5 · $13.15
Vs SPY
+17.79%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $11.22entry
  2. T+1 · 13d ago +4.90%α +3.25% · $11.77
  3. T+5 · 7d ago +17.20%α +17.79% · $13.15
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144 notice of intent to sell 2,407 shares of common stock, valued at approximately $26,718 based on the filing date price. The shares were acquired through restricted stock vesting on November 1, 2026. The proposed sale is small relative to the company's $2.0B market cap and appears to be a routine transaction to cover tax withholding or diversify holdings.

Key Facts

  • Officer Vanina de Verneuil filed Form 144 to sell 2,407 shares of Vir Biotechnology common stock.
  • Estimated aggregate value of the proposed sale is $26,717.70.
  • Shares were acquired on November 1, 2026 via restricted stock vesting from the issuer.
  • The sale is planned for execution on or after November 3, 2026 on Nasdaq.
  • The proposed sale represents a negligible fraction of the company's $2.0B market cap.

Financial Impact

Proposed sale of 2,407 shares worth approximately $26,718, immaterial relative to $2.0B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • No context on the officer's total beneficial ownership was provided, so proportionality to holdings cannot be fully assessed.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007669
Document: 0001959173-26-007669-index.html0001959173-26-007669
Document: 0001959173-26-007669.txt0001959173-26-007669

Track record

36 reports on VIR

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today 424B5 Bearish 5/10 Entry price pending
  2. Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
  3. Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
  4. Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
  5. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
  6. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
  7. Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
  8. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
  9. Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens Wed (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026